In addition, RBM24 expression in tumour tissues of CRC patients was dramatically reduced and the expression of RBM24 correlated significantly with the prognosis of CRC patients, which was consistent with the data from TCGA and GEPIA databases. This evidence concerns the gene RBM24 and colorectal carcinoma.